Condition
Lung Neoplasms, Non-Small Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Lung Neoplasms, Non-Small Cell Lung Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (2), Taiwan (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Lung Neoplasms, Non-Small Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic NSCLC | Phase 3 | Taipei, Taipei City | Recruiting | Jul 31, 2026 |
| Double-dose third-generation EGFR-TKI with bevacizumab and intrathecal chemotherapy for leptomeningeal NSCLC | — | Nanchang, Jiangxi | Recruiting | Feb 10, 2026 |
| Using a smartphone app to help lung cancer patients stick to their rehabilitation exercises after surgery | — | Zhongshan, Guangdong | Recruiting | Aug 14, 2023 |
All recruiting trials (3)
-
Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic NSCLC
This trial tests whether surgically removing the main lung tumor, after initial osimertinib therapy, helps people with EGFR-mutant oligometastatic non-small cell lung cancer live longer without disease progression.
-
Double-dose third-generation EGFR-TKI with bevacizumab and intrathecal chemotherapy for leptomeningeal NSCLC
This trial will try whether giving a double dose of a third-generation EGFR-TKI together with bevacizumab and spinal (intrathecal) chemotherapy can help people with EGFR-mutant NSCLC whose leptomeningeal metastasis progressed after a standard-dose third-generation EGFR-TKI.
-
Using a smartphone app to help lung cancer patients stick to their rehabilitation exercises after surgery
This study is testing whether a smartphone app can help lung cancer patients stick to their rehabilitation exercises after surgery by allowing them to report their symptoms and get feedback from their doctors.
Related topics
Quick answers
How many Lung Neoplasms, Non-Small Cell Lung Cancer clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.